SCHEMBL17879719

SCHEMBL17879719

CCOC(=O)c1cc2c(C)cn(C)c(=O)c2n1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.44
BAZ2B Q9UIF8 1/20 0.43
BAZ2A Q9UIF9 1/20 0.43
KDM4E B2RXH2 7/20 0.42
ALDH1A1 P00352 6/20 0.42
HSD17B10 Q99714 4/20 0.41
HPGD P15428 4/20 0.41
GAA P10253 2/20 0.41
TSHR P16473 2/20 0.41
RXFP1 Q9HBX9 1/20 0.40
MAPK1 P28482 1/20 0.40
GLA P06280 2/20 0.39
PKM P14618 1/20 0.39
RAB9A P51151 1/20 0.38
MAPT P10636 2/20 0.38
RECQL P46063 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ESR1 P03372 1/20 0.38
POLB P06746 2/20 0.37
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17879720 0.81 BRD4 (0.56) BRD4KDM4EALDH1A1HSD17B10HPGD
SCHEMBL15788367 0.80 MAPK1 (0.42) BAZ2BBAZ2AKDM4EALDH1A1HSD17B10
SCHEMBL17879717 0.80 UCHL1 (0.39) BRD4BAZ2BBAZ2AKDM4EALDH1A1
SCHEMBL17517333 0.76 ALDH1A1 (0.41) KDM4EALDH1A1HSD17B10HPGDGAA
SCHEMBL6803759 0.75 ESR1 (0.49) KDM4EALDH1A1GAAMAPK1TDP1
SCHEMBL7881193 0.73 KMT2A (0.54) KDM4EALDH1A1HPGDGAAMAPT
SCHEMBL13295979 0.73 ALDH1A1 (0.46) BAZ2BBAZ2AKDM4EALDH1A1HSD17B10
SCHEMBL22827048 0.72 BRD4 (0.35) BRD4BAZ2BBAZ2AKDM4EALDH1A1
SCHEMBL15788370 0.72 ALDH1A1 (0.48) KDM4EALDH1A1HPGDGAARXFP1
SCHEMBL24398095 0.72 TNF (0.38) BAZ2BBAZ2AKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9957263-B2 Bromodomain inhibitors ABBVIE INC. (US) 2018-05-01 US disclosed
US-20160185769-A1 Bromodomain Inhibitors ABBVIE INC. (US) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185769-A1 Bromodomain Inhibitors BRD1, BRD4, BRD3 BRD4 2/4885BAZ2B 12/4885BAZ2A 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.